Original source
Announcement / notice
国家药监局关于发布化妆品新原料注册备案及资料管理规定的公告（2026年第59号）
- Official date
- 2026-06-26
Unlock the official file
Business Impact stays free. Paid plans unlock the original source, official text, and Regulatory Details — plus Workbench and Verify credits.
Official source. NMPA Announcement No. 59 of 2026
Key points
- Standalone NCI registration/filing and data-management rule.
- Applies 15 July 2026; 2021 Announcement No. 31 is repealed.
- Risk-based classification of new ingredients remains the CSAR logic — confirm the new annexes for what you must submit.
- Finished-product filings cannot legalise an ingredient that is still an NCI.
Dates. Published 26 June 2026; applies 15 July 2026.
Verify in the official text. Classification tables, monitoring-period duties, and any grandfathering for files already accepted under No. 31.
Open questions. Confirm any transitional stock rules and whether your exact INCI / product type is named. This desk brief is a prioritisation aid, not a legal determination.
What changed: The 2021 NCI dossier rule is replaced from 15 July 2026.
Who is affected: Ingredient suppliers, China RPs, and brands whose 2026–27 launches depend on new INCIs.
Suggested next steps: 1. Download No. 59 and map each pipeline NCI to the new annex.
2. Ask whether in-flight files must be supplemented.
3. Separate NCI timeline from finished-product launch timeline.
On 26 June 2026 NMPA published new provisions for registration, filing and data management of new cosmetic ingredients (Announcement No. 59), applying from 15 July 2026 and repealing the 2021 No. 31 rule.
This is high priority if you have an NCI in review, a 3-year monitoring ingredient, or a 2026 launch that depends on a new INCI in China.
Business risk is high because a wrong dossier template burns a season, not a week.
This week: freeze whether each pipeline ingredient is “new” under CSAR, and ask RA which template No. 59 now wants.
Do not assume a finished-product filing can carry an unapproved NCI.
Official text
English translation — the official-language text prevails
Unofficial English translation of NMPA Announcement No. 59 of 2026 (26 June 2026). The Chinese official text prevails.
In order to accelerate research and innovation of new cosmetic ingredients and promote high-quality industry development, and in accordance with the Cosmetic Supervision and Administration Regulation and the Measures for the Administration of Cosmetic Registration and Filing, NMPA has organised and formulated the Provisions on the Registration, Filing and Data Management of New Cosmetic Ingredients. They are hereby issued and apply from 15 July 2026.
The Announcement of NMPA on Issuing the Provisions on the Administration of Registration and Filing Dossiers for New Cosmetic Ingredients (No. 31 of 2021) is repealed at the same time.
The annexed Provisions (not reproduced in full here) replace the 2021 dossier rule for new-ingredient registration and filing. Finished-product registration/filing does not legalise an ingredient that is still a new cosmetic ingredient. Read the annexes of No. 59 for classification, dossier lists and monitoring-period duties.